Methods for non-invasive prenatal ploidy calling
AssigneeNatera, Inc.
InventorsMatthew Rabinowitz, George Gemelos, Milena Banjevic, Allison Ryan, Zachary Demko, Matthew Hill, Bernhard Zimmermann, Johan Baner
Life of this patent
Estimating the term…
Loading patent…
AssigneeNatera, Inc.
InventorsMatthew Rabinowitz, George Gemelos, Milena Banjevic, Allison Ryan, Zachary Demko, Matthew Hill, Bernhard Zimmermann, Johan Baner
Estimating the term…
The present disclosure provides methods for determining the ploidy status of a chromosome in a gestating fetus from genotypic data measured from a sample of DNA from the mother of the fetus and from the fetus, and from genotypic data from the mother and optionally also from the father. The ploidy state is determined by using a joint distribution model to create a set of expected allele distributions for different possible fetal ploidy states given the parental genotypic data, and comparing the expected allelic distributions to the pattern of measured allelic distributions measured in the mixed sample, and choosing the ploidy state whose expected allelic distribution pattern most closely matches the observed allelic distribution pattern. In an embodiment, the mixed sample of DNA may be preferentially enriched at a plurality of polymorphic loci in a way that minimizes the allelic bias.
A method for preparing a preparation of amplified and enriched DNA derived from a biological sample comprising cell-free DNA of maternal origin and cell-free DNA of fetal origin useful for fetal fraction analysis, comprising:
A method for preparing a preparation of amplified and enriched DNA derived from a maternal blood, plasma, or serum sample comprising cell-free DNA of maternal origin and cell-free DNA of fetal origin useful for fetal fraction analysis, comprising:
Dependencies are inferred from the claim text.